FMO5 and obesity disorder: In energy metabolism, NAD(P)H is consumed by NAD(P)H oxidase (NOX) to generate reactive oxygen species (ROS), which inhibit insulin secretion and disrupt glucose and lipid homeostasis, contributing to obesity [18].